Epirium Bio is a company that develops therapeutics designed to promote mitochondrial biogenesis and function. It offers insights related to the biology of mitochondrial biogenesis and has identified and established an IP-protected platform of small molecules that constitute a new class of therapeutics with the potential to stimulate mitochondrial biogenesis and tissue regeneration, enabling physicians to access therapeutic for intractable neuromuscular diseases.